Table 2.

In-hospital outcomes of the patients included in the analysis before & after the propensity score matching.

Variables no.(%)	Unmatched cohorts				Matched cohorts
	Cancer	No cancer	Total	p-value	Cancer	No cancer	Total	p-value
	(n = 5956)	(n = 379,566)	(n = 385,522)		(n = 5949)	(n = 17,931)	(n = 23,880)
In-hospital outcomes Death	26.6	11.3	11.6	<0.01	26.6	21.5	22.8	<0.01
Vascular complications	1.4	1.5	1.5	0.57	1.4	1.3	1.3	0.76
Bleeding complications	24.5	12.1	12.3	<0.01	24.5	15.7	17.9	<0.01
Post-procedural bleeding	10.1	6.4	6.4	<0.01	10.1	6.8	7.6	<0.01
Gastrointestinal bleeding	7.8	3.0	3.1	<0.01	7.8	5.0	5.7	<0.01
Intracranial hemorrhage	1.0	0.4	0.4	<0.01	1.0	0.7	0.7	0.055
Hematuria	2.4	1.2	1.2	<0.01	2.4	1.8	1.9	0.09
Blood transfusion	10.8	3.9	4	<0.01	10.8	6.2	7.4	<0.01
Severe disability surrogates
Non-home discharge	17.5	10.4	10.5	<0.01	17.5	17.7	17.6	0.79
Mechanical ventilation	19.5	12.7	12.8	<0.01	19.4	18.8	18.9	0.42
Resources utilization
Length of hospitalization median days (25th–75th IQR)	4 (2–8)	3 (2–5)	3 (2–5)	<0.01	4 (2–8)	3 (2–6)	3 (2–6)	<0.01
Total cost of hospitalization median $ (25th–75th IQR)	18,479 (10,960–30,241)	19,416 (13,830–28,758)	19,405 (13,797–28,783)	<0.01	18,540 (10,936–30,721)	16,821 (9,741–27,259)	17,299 (10,046–28,059)	<0.01